According to Palmer (2000), SIADH is an expansion of extracellular fluid volume resulting from the superfluous release of antidiuretic hormone (ADH) or increased renal sensitivity to ADH.

The investigators subsequently monitored the long-term effects of dose-adjusted satavaptan treatment in the same group of patients with SIADH. Ten patients completed the 12-month open-label study ...

New Delhi: Considering the published data on efficacy studies of Tolvaptan Tablets 7.5 mg, the Subject Expert Committee (SEC) ...